Novonesis_Logo (1).png
Major shareholder announcement
05. September 2024 07:07 ET | Novozymes A/S
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital...
Novonesis_Logo (1).png
Trading by management and close relations of management
02. September 2024 12:36 ET | Novozymes A/S
Please read the full announcement in PDF Attachment 2024_31_Trading_By_Management ...
Novonesis_Logo (1).png
Trading by management and close relations of management
02. September 2024 12:27 ET | Novozymes A/S
Please read the full announcement in PDF Attachment 2024_30_Trading_By_Management ...
Novonesis_Logo (1).png
Trading by management and close relations of management
30. August 2024 06:17 ET | Novozymes A/S
Please read the full announcement in PDF Attachment 2024_29_Trading_By_Management ...
Novonesis_Logo (1).png
Major shareholder announcement
29. August 2024 09:17 ET | Novozymes A/S
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital...
Novonesis_Logo (1).png
Novonesis delivers strong half-year results and increases full-year outlook
27. August 2024 10:34 ET | Novozymes A/S
In the first half of 2024, Novonesis delivered 7% organic sales growth with an adjusted EBITDA margin at 35.3%. Following strong first half-year performance, Novonesis increases its full-year organic...
Novonesis_Logo (1).png
Interim Report H1 2024
27. August 2024 10:30 ET | Novozymes A/S
H1 organic pro forma sales growth at 7%, with pro forma adjusted EBITDA margin at 35.3%. Full-year outlook increased.   H1 organic pro forma sales growth of 7% and 8% on IFRS reported basis. Q2...
Novonesis_Logo (1).png
Novonesis increases outlook for full year 2024
27. August 2024 10:29 ET | Novozymes A/S
Novonesis increases its full-year sales and profitability outlook based on the first half year performance coupled with strong momentum going into the first months of the second half.The 2024 outlook...
Novonesis_Logo (1).png
Major shareholder announcement
16. August 2024 10:40 ET | Novozymes A/S
Please see the full announcement in PDF  Attachments 2024_25_Major_Shareholders_Announcement Novozymes B 13 Aug 2024 Final ...
Novonesis_Logo (1).png
Major shareholder announcement
26. Juni 2024 08:08 ET | Novozymes A/S
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis, that as of June 21, BlackRock, Inc. crossed the 5% threshold...